Patent Baristas

MedImmune and Genentech have announced that they reached a settlement regarding their patent lawsuit over MedImmune’s best-selling drug Synagis®, which is used to prevent respiratory infections in infants.  “The parties advise the court that they have reached a settlement,” according to a telephone conference recorded on the docket in the U.S. District Court for the […]

“Let every nation know, whether it wishes us well or ill, that we shall pay any price, bear any burden, meet any hardship, support any friend, oppose any foe to assure the survival and the success of liberty.” ~ John F. Kennedy In Memoriam Welcome to the Memorial Day Edition of Blawg Review. I’m not […]

LegalZoom, co-founded by Robert L. Shapiro of People v. O.J. Simpson fame, is a do-it-yourself website for getting legal documents but not legal advice. But, of course, this raises the question: if they’re not giving you legal advice, what is it you’re getting for your money?  Well, it appears you get some forms filled out […]

Brand-name and generic medicines: Both play an important role in health care today by Larry Lucas My job representing America’s pharmaceutical research companies requires me to be on the road a lot. As a “road warrior,” I spend a great deal of time in communities across the country talking to patients about the health care […]

While it seems that just about everyone is jumping on the green bandwagon, there is money to be had in global disaster, too. Climate change can be profitable. Human-induced climate change could trigger climate shocks in all ecosystems that will profoundly affect crops, livestock, fisheries and forests and the billions of people whose livelihoods depend […]

The indefatigable Blawg Review Editor has asked Patent Baristas to host the next Blawg Review after Aussie law professor Mirko Bagaric of Moral Dilemma was unable to fulfill his duties due to an unexpected scheduling conflict with a case. In the interest of God, Country and mercy, please send me your suggested additions to Blawg Review […]

The book “Patent Appeals: The Elements of Effective Advocacy in the Federal Circuit” by Mark Simon Davies (Oxford University Press, USA) provides detailed guidance for IP lawyers on the requirements for an appellate brief set out in the Federal Rules of Appellate Procedure 28(a).  The book inherently focuses on the U.S. Court of Appeals for […]

Biovail Corp., Canada’s largest publicly traded drugmaker, announced that it has settled with the United States Department of Justice (DOJ) regarding criminal allegations related to activities surrounding the 2003 commercial launch of Cardizem LA. The DOJ alleges that prior management’s actions in 2002 and 2003 in respect of the Cardizem LA clinical experience program, titled […]